ArticleFrontiers in oncology2022

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience.

Li-Ching Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.